Clinical Trial Update: A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study comparing blood levels of the cagrilintide/semaglutide combination after single doses of different versions of Injectable CagriSem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• CagriSema (cagrilintide/semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 1 | Status: COMPLETED